EVOKE WEALTH, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1793432 Los Angeles, CA

Position in REGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$888,536

+$263,322 QoQ

Shares Held

1,150

+42.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

EVOKE WEALTH, LLC holds $4,430,822 across 13 Biotechnology names. REGN ranks #1 (20.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	1,150	$888,536
2	INCY	Incyte Corp	8,503	$800,302
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,485	$663,111
4	KALV	KalVista Pharmaceuticals, Inc.	31,542	$634,940
5	BMRN	Biomarin Pharmaceutical Inc	4,890	$276,236
6	EXEL	Exelixis, Inc.	5,807	$249,062
7	ALNY	Alnylam Pharmaceuticals, Inc.	693	$229,292
8	SMMT	Summit Therapeutics Inc.	10,668	$202,265

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$888,536	1,150	+42.0%	Shares	Sole	2026-05-15
2025-12-31	$625,214	810	+35.2%	Shares	Sole	2026-02-06
2025-09-30	$336,799	599	+93.9%	Shares	Sole	2025-11-14
2023-06-30	$222,028	309	+301.3%	Shares	Sole	2023-08-09
2022-09-30	$53,042	77	-2.5%	Shares	Sole	2022-11-07
2022-06-30	$46,699	79	+11.3%	Shares	Sole	2022-08-04
2022-03-31	$49,587	71	+24.6%	Shares	Sole	2022-05-10
2021-12-31	$35,996	57	-1.7%	Shares	Sole	2022-02-09
2021-09-30	$35,100	58	+427.3%	Shares	Sole	2021-11-12
2021-06-30	$6,143	11	0.0%	Shares	Sole	2021-08-05
2021-03-31	$5,204	11	+57.1%	Shares	Sole	2021-05-13
2020-12-31	$3,381	7	-30.0%	Shares	Sole	2021-02-12
2020-09-30	$5,597	10	+42.9%	Shares	Sole	2020-11-13
2020-06-30	$4,365	7	0.0%	Shares	Sole	2020-08-10
2020-03-31	$3,418	7	—	Shares	Sole	2020-05-07
No filing history on record for this holder in this stock.